The CEO of a biomedical company has stated that a vaccine for the coronavirus could be ready to hit the market at the end of the year.
According to The Hill:
The CEO of Moderna, one of the biotech companies working to develop a coronavirus vaccine, said on Wednesday that one could be ready to be sent to the Food and Drug Administration (FDA) by the end of this year.
“It is possible — assuming a best-case scenario and there are many risks that could derail us, obviously — but we could potentially be in a position to file to the FDA toward the end of the year or early next year,” Stéphane Bancel said on Fox Business’s “Mornings with Maria.”
“Again, it’s a best-case scenario,” he emphasized.
Moderna announced this week that early data from a phase one clinical trial showed that people given a potential vaccine generated an immune response similar to one in people who had recovered from the disease. Additionally, company’s potential vaccine was successful in preventing the virus from replicating in mice’s lungs in another study, it said.
The company is currently moving into phase 2 of testing and will be ready by July to hopefully move in to phase 3.